Tag: NHS

Novartis announces intent to collaborate with NHS to tackle burden of cardiovascular disease

novartis
Novartis announced its intent to collaborate with NHS England focused on addressing cardiovascular disease (CVD); a significant cause of disability and death in the UK. The current proposal is to c...

Pfizer’s Ibrance Approved for Use by NHS in England

Pfizer’s Ibrance has been approved for use by the NHS in England as a second-line treatment for advanced breast cancer after hormonal therapy, catching up with rival drugs in the class. The decision ...

NHS Wales Accepted Offer for Licensed Vertex Cystic Fibrosis Medicines

Vertex Pharmaceuticals Incorporated confirms that NHS Wales has accepted an offer for all currently licensed Vertex cystic fibrosis (CF) medicines and any future indications of these medicines under t...

Vertex Announced Access Agreement with NHS England for All Licensed CF Medicines

Vertex Pharmaceuticals Incorporated announced an access agreement with NHS England for all currently licensed Vertex cystic fibrosis (CF) medicines and any future indications of these medicines. Th...

Poor Diabetes Control Costs NHS £3bn

New research finds that poor diabetes control costs the NHS £3bn in potentially avoidable hospital treatment in England. The findings, being presented at this year’s European Association for the St...

NICE Recommended Use of Takeda’s Takhzyro on NHS

takeda
The National Institute for Health and Clinical Excellence (NICE) - a health technology appraisal body in England and Wales - has recommended the use of Takeda’s Takhzyro (lanadelumab) on the NHS. A...

UK Government Invests over £130 mln to Tackle Serious Diseases

The UK government has announced an investment of over £130 million for new tech to tackle cancer and debilitating illnesses. The news means that thousands of NHS patients could receive faster diagn...

Novartis Luxturna® Recommended by NICE

Novartis Luxturna®, a novel gene therapy treatment for rare inherited eye disorder, has been recommended by NICE for use on the NHS. The draft highly-specialised technologies guidance recommends vo...

ABPI and NHS to Launch New Guidance for Joint Working

The Association of the British Pharmaceutical Industry (ABPI) has launched a new guidance for joint working between the NHS and industry, which sets out a ten-step process to scope, set up and monitor...

NHS Plan to Use More Generics Could Save Up to £700m

An NHS-wide plan to use more generic and biologic products has reportedly saved the healthcare provider £700 million since 2016. The National Health Service (NHS), UK, has announced that its initiati...

No-Deal Brexit Could “Devastate” NHS, Health Leaders Warn

A no-deal Brexit could “devastate” the NHS by disrupting the supply of life-saving medicine by up to six months, health leaders have warned. The British Medical Association, Royal College of Nursin...

NHS England Scrapped Seven Medicines from its Prescriptions List

NHS England has issued a new guidance scrapping seven medicines from its prescriptions list, estimating to save around £141 million a year. Among the treatments are hypertension medication aliskire...

NICE Published Amended Draft Guidance for Spinraza

More children with the rare genetic disorder spinal muscular atrophy (SMA) can now be treated with Spinraza after on 3 July NICE published amended draft guidance following a proposal for extending t...

NHS England Provided £2m to Boost Leadership Development in UK Health System

The programme is designed to help 23 areas kick-start or boost leadership development activities to support and inspire workforce in health systems across England from GPs, consultants and therapists ...

NHS, Gilead, MSD and AbbVie Collaborate to Help Eliminate Hepatitis C

The NHS will find and cure tens of thousands more people with hepatitis C as part of a ground-breaking deal that could help England become the first country in the world to eliminate the deadly virus....

UK Breakthrough Plan for AMR

A new reimbursement model for antibiotics by the NHS and NICE is being labelled as a ‘great breakthrough’. The model is part of the government’s new national action plan on how it will fight agains...